XML 66 R54.htm IDEA: XBRL DOCUMENT v3.26.1
SEGMENTS - Summarized Financial Information Concerning Reportable Segments (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
SEGMENTS [Abstract]          
Revenues $ 124,395 $ 121,984 $ 238,888 $ 236,786  
Cost of product revenue 38,118 54,757 71,861 108,463  
Research and development 6,014 1,031 8,611 1,858  
Plasma center operating expenses 6,135 4,963 12,464 9,587  
Gain on sale of plasma centers 0 0 (7,980) 0  
Amortization of intangible assets 55 32 110 57  
Depreciation and amortization expense     3,620 4,027  
Other income (expense), net (2,208) (2,701) (3,354) (4,132)  
Income (loss) before taxes 50,237 40,097 107,365 73,546  
Total assets 684,210 558,380 684,210 558,380 $ 624,242
Reconciliation of income before taxes:          
Loss on extinguishment of debt 0 (1,159) 0 (1,159)  
Reconciliation of selling, general and administrative expense:          
Consolidated selling, general and administrative expense 26,737 22,214 53,479 46,292  
Reconciliation of income (loss) before taxes:          
Unallocated interest expense, primarily related to interest on senior debt (see Note 6) 3,424 1,834 5,524 3,809  
Operating Segments [Member]          
SEGMENTS [Abstract]          
Revenues 124,360 121,948 238,817 236,715  
Cost of product revenue 38,118 54,757 71,861 108,463  
Research and development 6,014 1,031 8,611 1,858  
Plasma center operating expenses 1,026 1,152 2,088 2,438  
Gain on sale of plasma centers 0   (7,980)    
Selling, marketing and distribution 7,634 5,868 14,830 11,911  
Amortization of intangible assets   32   57  
Depreciation and amortization expense 1,780   3,620    
General and administrative expense 8,340 14,941 16,798 30,024  
Other income (expense), net 130 (108) 11 (172)  
Income (loss) before taxes 63,303 44,059 132,510 81,792  
Expenditures for additions to long-lived assets 2,256 2,027 4,799 6,747  
Total assets 475,402 397,390 475,402 397,390  
Operating Segments [Member] | ADMA BioManufacturing [Member]          
SEGMENTS [Abstract]          
Revenues 123,637 121,948 237,378 235,665  
Cost of product revenue 37,564 54,757 70,514 107,814  
Research and development 6,014 1,031 8,611 1,858  
Plasma center operating expenses 0 0 0 0  
Gain on sale of plasma centers 0   0    
Selling, marketing and distribution 7,634 5,868 14,830 11,911  
Amortization of intangible assets   32   57  
Depreciation and amortization expense 1,281   2,556    
General and administrative expense 8,340 14,941 16,798 30,024  
Other income (expense), net (20) (108) (207) (172)  
Income (loss) before taxes 64,010 45,211 126,308 83,829  
Expenditures for additions to long-lived assets 2,256 2,034 4,772 6,733  
Total assets 453,538 368,229 453,538 368,229  
Operating Segments [Member] | Plasma Collection Centers [Member]          
SEGMENTS [Abstract]          
Revenues 723 0 1,439 1,050  
Cost of product revenue 554 0 1,347 649  
Research and development 0 0 0 0  
Plasma center operating expenses 1,026 1,152 2,088 2,438  
Gain on sale of plasma centers 0   (7,980)    
Selling, marketing and distribution 0 0 0 0  
Amortization of intangible assets   0   0  
Depreciation and amortization expense 499   1,064    
General and administrative expense 0 0 0 0  
Other income (expense), net 150 0 218 0  
Income (loss) before taxes (707) (1,152) 6,202 (2,037)  
Expenditures for additions to long-lived assets 0 (7) 27 14  
Total assets 21,864 29,161 21,864 29,161  
Reconciling Item [Member]          
SEGMENTS [Abstract]          
Revenues 35 36 71 71  
Income (loss) before taxes 35 36 71 71  
Reconciliation of income before taxes:          
Loss on extinguishment of debt   (1,159)   (1,159)  
Reconciliation of income (loss) before taxes:          
Unallocated interest expense, primarily related to interest on senior debt (see Note 6) (3,425) (1,834) (5,520) (3,809)  
Unallocated interest income 1,087 400 2,155 1,008  
Reconciling Item [Member]          
SEGMENTS [Abstract]          
General and administrative expense [1] 10,763 1,405 21,851 4,357  
Income (loss) before taxes [1] (10,763) (1,405) (21,851) (4,357)  
Total assets $ 208,808 $ 160,990 [2] $ 208,808 $ 160,990 [2]  
[1] - Primarily includes compensation expense, including stock-based compensation expense, for certain executive officers and consultants, insurance, legal and investor relations expenses and accounting and tax fees that are not allocated to the Company's operating segments.
[2] - Primarily consists of cash and deferred tax assets.